281 related articles for article (PubMed ID: 12457445)
21. Development of polycystic ovary syndrome: involvement of genetic and environmental factors.
Franks S; McCarthy MI; Hardy K
Int J Androl; 2006 Feb; 29(1):278-85; discussion 286-90. PubMed ID: 16390494
[TBL] [Abstract][Full Text] [Related]
22. Association of insulin gene VNTR polymorphism with polycystic ovary syndrome.
Vanková M; Vrbíková J; Hill M; Cinek O; Bendlová B
Ann N Y Acad Sci; 2002 Jun; 967():558-65. PubMed ID: 12079889
[TBL] [Abstract][Full Text] [Related]
23. Genetic Studies on Polycystic Ovary Syndrome.
Zhao H; Lv Y; Li L; Chen ZJ
Best Pract Res Clin Obstet Gynaecol; 2016 Nov; 37():56-65. PubMed ID: 27264388
[TBL] [Abstract][Full Text] [Related]
24. Association between genes encoding components of the Leutinizing hormone/Luteinizing hormone-choriogonadotrophin receptor pathway and polycystic ovary syndrome in Egyptian women.
El-Shal AS; Zidan HE; Rashad NM; Abdelaziz AM; Harira MM
IUBMB Life; 2016 Jan; 68(1):23-36. PubMed ID: 26662070
[TBL] [Abstract][Full Text] [Related]
25. Role of the pentanucleotide (tttta)n polymorphisms of Cyp11alpha gene in the pathogenesis of hyperandrogenism in Chinese women with polycystic ovary syndrome.
Tan L; Zhu G
J Huazhong Univ Sci Technolog Med Sci; 2005; 25(2):212-4. PubMed ID: 16116976
[TBL] [Abstract][Full Text] [Related]
26. CYP11A1 and CYP17 promoter polymorphisms associate with hyperandrogenemia in polycystic ovary syndrome.
Pusalkar M; Meherji P; Gokral J; Chinnaraj S; Maitra A
Fertil Steril; 2009 Aug; 92(2):653-9. PubMed ID: 18725155
[TBL] [Abstract][Full Text] [Related]
27. Polycystic ovary syndrome and metabolic syndrome.
Ali AT
Ceska Gynekol; 2015 Aug; 80(4):279-89. PubMed ID: 26265416
[TBL] [Abstract][Full Text] [Related]
28. Enzymatic activities of P450c17 stably expressed in fibroblasts from patients with the polycystic ovary syndrome.
Martens JW; Geller DH; Arlt W; Auchus RJ; Ossovskaya VS; Rodriguez H; Dunaif A; Miller WL
J Clin Endocrinol Metab; 2000 Nov; 85(11):4338-46. PubMed ID: 11095477
[TBL] [Abstract][Full Text] [Related]
29. Overexpression of a DENND1A isoform produces a polycystic ovary syndrome theca phenotype.
McAllister JM; Modi B; Miller BA; Biegler J; Bruggeman R; Legro RS; Strauss JF
Proc Natl Acad Sci U S A; 2014 Apr; 111(15):E1519-27. PubMed ID: 24706793
[TBL] [Abstract][Full Text] [Related]
30. Genetics of the polycystic ovary syndrome.
Kosova G; Urbanek M
Mol Cell Endocrinol; 2013 Jul; 373(1-2):29-38. PubMed ID: 23079471
[TBL] [Abstract][Full Text] [Related]
31. Association of the steroid synthesis gene CYP11a with polycystic ovary syndrome and hyperandrogenism.
Gharani N; Waterworth DM; Batty S; White D; Gilling-Smith C; Conway GS; McCarthy M; Franks S; Williamson R
Hum Mol Genet; 1997 Mar; 6(3):397-402. PubMed ID: 9147642
[TBL] [Abstract][Full Text] [Related]
32. [Epidemiology and genetics of polycystic ovary syndrome: recent date].
Strauss JF
J Gynecol Obstet Biol Reprod (Paris); 2003; 32(3 Pt 2):S11-6. PubMed ID: 12773913
[No Abstract] [Full Text] [Related]
33. Quantitative analysis of follistatin (FST) promoter methylation in peripheral blood of patients with polycystic ovary syndrome.
Sang Q; Zhang S; Zou S; Wang H; Feng R; Li Q; Jin L; He L; Xing Q; Wang L
Reprod Biomed Online; 2013 Feb; 26(2):157-63. PubMed ID: 23265961
[TBL] [Abstract][Full Text] [Related]
34. Current concepts in the polycystic ovary syndrome.
Dunaif A; Thomas A
Annu Rev Med; 2001; 52():401-19. PubMed ID: 11160786
[TBL] [Abstract][Full Text] [Related]
35. Polycystic ovary syndrome in adolescents.
Franks S
Int J Obes (Lond); 2008 Jul; 32(7):1035-41. PubMed ID: 18458678
[TBL] [Abstract][Full Text] [Related]
36. Polycystic ovary syndrome: evidence for a primary disorder of ovarian steroidogenesis.
Franks S; Gharani N; Gilling-Smith C
J Steroid Biochem Mol Biol; 1999; 69(1-6):269-72. PubMed ID: 10419001
[TBL] [Abstract][Full Text] [Related]
37. Trp28Arg/Ile35Thr LHB gene variants are associated with elevated testosterone levels in women with polycystic ovary syndrome.
Batista MC; Duarte Ede F; Borba MD; Zingler E; Mangussi-Gomes J; dos Santos BT; de Moraes OL; Hayashida SA; Baracat EC; da Rocha Neves Fde A; Maciel GA; Bachega TA; Barra GB; Lofrano-Porto A
Gene; 2014 Oct; 550(1):68-73. PubMed ID: 25111116
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of association between the CYP11alpha promoter pentannucleotide (TTTTA)n polymorphism and polycystic ovarian syndrome among Han Chinese women.
Hao CF; Bao HC; Zhang N; Gu HF; Chen ZJ
Neuro Endocrinol Lett; 2009 Mar; 30(1):56-60. PubMed ID: 19300392
[TBL] [Abstract][Full Text] [Related]
39. The role of polymorphism in various potential genes on polycystic ovary syndrome susceptibility and pathogenesis.
Chaudhary H; Patel J; Jain NK; Joshi R
J Ovarian Res; 2021 Sep; 14(1):125. PubMed ID: 34563259
[TBL] [Abstract][Full Text] [Related]
40. Metabolism and insulin signaling in common metabolic disorders and inherited insulin resistance.
Højlund K
Dan Med J; 2014 Jul; 61(7):B4890. PubMed ID: 25123125
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
